This article is a narrative review with the main objective of describing the technical versatility of Duodenal Transit Bipartition (DTB). DTB represents an adaption of the classic transit bipartition concept, in which the anastomosis is shifted to a post-pyloric position in the duodenum. This technical modification preserves the pylorus and gastroduodenal continuity while creating a second pathway that directs part of the gastrointestinal content—along with bile and pancreatic secretions—early to the distal intestine. The procedure is characterized by its high technical versatility, allowing different combinations with gastric procedures (Laparoscopic Sleeve Gastrectomy, Endoscopic Sleeve Gastroplasty, or proportional Gastric Sleeve), different anastomotic techniques (manual, stapled, or magnetic), and different anastomotic locations along the duodenal segments. From a physiological standpoint, DTB probably promotes early stimulation of distal enteroendocrine L cells, potentially increasing postprandial secretion of GLP-1 and PYY. Additionally, the early arrival of bile acids to the ileum may activate the FXR-FGF19 and TGR5-GLP-1 pathways, influencing hepatic metabolism, hormonal secretion, and energy balance. It would not be appropriate to attribute the metabolic effects of DTB, or other metabolic surgical procedures, exclusively to a single mechanism. The metabolic benefit of these metabolic procedures likely derives primarily from the interaction between anatomical alterations, nutrient flow, intestinal signaling, bile acids, and secondarily from caloric reduction and weight loss. The preservation of pyloric control may reduce the risks of dumping syndrome and reactive hypoglycemia while maintaining physiological gastric emptying. This article reviews the technical aspects, physiological rationale, and clinical versatility of DTB, discussing its potential role as an adaptable metabolic procedure for patients with obesity and type 2 diabetes.
References
[1]
Schauer, P.R., Mingrone, G., Ikramuddin, S. and Wolfe, B. (2016) Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes. DiabetesCare, 39, 902-911. https://doi.org/10.2337/dc16-0382
[2]
Rubino, F., Nathan, D.M., Eckel, R.H., Schauer, P.R., Alberti, K.G.M.M., Zimmet, P.Z., et al. (2016) Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surgery for ObesityandRelatedDiseases, 12, 1144-1162. https://doi.org/10.1016/j.soard.2016.05.018
[3]
Dixon, J.B., Zimmet, P., Alberti, K.G. and Rubino, F. (2011) Bariatric Surgery: An IDF Statement for Obese Type 2 Diabetes. DiabeticMedicine, 28, 628-642. https://doi.org/10.1111/j.1464-5491.2011.03306.x
[4]
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., et al. (2021) Metabolic Surgery versus Conventional Medical Therapy in Patients with Type 2 Diabetes: 10-Year Follow-Up of an Open-Label, Single-Centre, Randomised Controlled Trial. TheLancet, 397, 293-304. https://doi.org/10.1016/s0140-6736(20)32649-0
[5]
Drucker, D.J. (2018) Mechanisms of Action and Therapeutic Application of Glucagon-Like Peptide-1. CellMetabolism, 27, 740-756. https://doi.org/10.1016/j.cmet.2018.03.001
[6]
Holst, J.J. (2007) The Physiology of Glucagon-Like Peptide 1. PhysiologicalReviews, 87, 1409-1439. https://doi.org/10.1152/physrev.00034.2006
[7]
Batterham, R.L. and Bloom, S.R. (2003) The Gut Hormone Peptide YY Regulates Appetite. AnnalsoftheNewYorkAcademyofSciences, 994, 162-168. https://doi.org/10.1111/j.1749-6632.2003.tb03176.x
[8]
Fiorucci, S. and Distrutti, E. (2015) Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders. TrendsinMolecularMedicine, 21, 702-714. https://doi.org/10.1016/j.molmed.2015.09.001
[9]
Ryan, K.K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., et al. (2014) FXR Is a Molecular Target for the Effects of Vertical Sleeve Gastrectomy. Nature, 509, 183-188. https://doi.org/10.1038/nature13135
[10]
Potthoff, M.J., Kliewer, S.A. and Mangelsdorf, D.J. (2012) Endocrine Fibroblast Growth Factors 15/19 and 21: From Feast to Famine. Genes&Development, 26, 312-324. https://doi.org/10.1101/gad.184788.111
[11]
Azevedo, F.R., Santoro, S., Correa-Giannella, M.L., Toyoshima, M.T., Giannella-Neto, D., Calderaro, D., et al. (2018) A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition. Obesity Surgery, 28, 3012-3019. https://doi.org/10.1007/s11695-018-3239-3
[12]
Santoro, S. (2008) Adaptive and Neuroendocrine Procedures: A New Pathway in Bariatric and Metabolic Surgery. ObesitySurgery, 18, 1343-1345. https://doi.org/10.1007/s11695-008-9550-7
[13]
de Melo, P.R.R.E., Dib, V.R.M., Madalosso, C.A.S., d’Almeida, L.A.V., de Godoy, E.P., Chaim, E.A., et al. (2026) Long-Term Outcome of Isolated Duodenal Transit Bipartition as Initial Metabolic Surgery: A 19-Year Follow-Up Case Report. American JournalofCaseReports, 27, e950650. https://doi.org/10.12659/ajcr.950650
[14]
Melo, P.R.E.D., Zorron, R., Dib, V.R.M., Madalosso, C.A.S., Ribeiro, R., Braga, T.C., et al. (2024) Sleeve Gastrectomy with Duodenal Transit Bipartition (S-DTB): Preliminary Results and Technical Aspects of Its Metabolic Structure. Surgical Science, 15, 244-264. https://doi.org/10.4236/ss.2024.154024
[15]
Melo, P.R.R.E.D., Hoff, A.C., Zorron, R., Dib, V.R.M., Madalosso, C.A.S., Ribeiro, R., et al. (2024) Hybrid Duodenal Transit Bipartition: An Endoscopic and Laparoscopic Metabolic Procedure. SurgicalScience, 15, 547-564. https://doi.org/10.4236/ss.2024.1510052
[16]
Esselin de Melo, P.R., Braga, T.C., Minari, D.F. and Cardoso Resende, J.H. (2022) Transit Bipartition with Duodeno-Ileal Anastomosis, without Duodenal Exclusion, as a First Stage of Bariatric Surgery in Severely Obese Patients: Case Report. Surgical Science, 13, 497-505. https://doi.org/10.4236/ss.2022.1311058
[17]
Melo, P.R.R.E.D., Dib, V.R.M., Madalosso, C.A.S., Parmar, C., Ghanem, O., Carbajo, M.á., et al. (2025) Metabolic Surgery: Concepts and New Classification. SurgicalScience, 16, 87-109. https://doi.org/10.4236/ss.2025.162011
[18]
Godoy, E.P.D., Pereira, S.S.D.S., Coelho, D., Pinto, I.M.D.M., Luz, V.F.D., Coutinho, J.L., et al. (2019) Biparti??o de transito intestinal isolada: Uma nova estratégia para cirurgia em estágios em superobesos. RevistadoColégioBrasileirodeCirurgi?es, 46, e20192264. https://doi.org/10.1590/0100-6991e-20192264
[19]
Romero, R.J. and Colorado-Subizar, R. (2020) Gastro-Ileal Anastomosis Bypass—Exploring for an Expanding Surgical Treatment for Diabetes in Patients with Low Body Mass Index. InternationalJournalofSurgeryCaseReports, 68, 22-26. https://doi.org/10.1016/j.ijscr.2020.01.051
[20]
Kawahara, N.T., Abujamra, S., Bremm, L.C., Kruel, N., Kawahara, L., Nocca, D., et al. (2026) A New Paradigm in Metabolic Surgery: Jejunal Bipartition. Journal of Laparoendoscopic&AdvancedSurgicalTechniques, 36, 100-104. https://doi.org/10.1177/10926429251413541
[21]
DePaula, A.L., Ugale, S.M., Branco, A.J., Dutra, C.C.L.P., Ugale, A., Ugale, A., et al. (2023) Ileal Interposition with Sleeve Gastrectomy for Type 2 Diabetes Mellitus and Metabolic Syndrome. In: Agrawal, S., Ed., Obesity, Bariatric and Metabolic Surgery, Springer International Publishing, 843-866. https://doi.org/10.1007/978-3-030-60596-4_58
[22]
Gagner, M., Cadiere, G., Sanchez-Pernaute, A., Abuladze, D., Krinke, T., Buchwald, J.N., et al. (2023) Side-to-Side Magnet Anastomosis System Duodeno-Ileostomy with Sleeve Gastrectomy: Early Multi-Center Results. SurgicalEndoscopy, 37, 6452-6463. https://doi.org/10.1007/s00464-023-10134-6
[23]
Dziakova, J., Torres, A., Odovic, M., Esteban, J.M., Vázquez-Romero, M., Castillo, A., et al. (2024) Spanish Experience with Latero-Lateral Duodeno-Ileostomy + Sleeve Gastrectomy with Magnet Anastomosis System. ObesitySurgery, 34, 3569-3575. https://doi.org/10.1007/s11695-024-07432-w
[24]
Castedal, M., Bj?rnsson, E. and Abrahamsson, H. (1998) Postprandial Peristalsis in the Human Duodenum. Neurogastroenterology&Motility, 10, 227-233. https://doi.org/10.1046/j.1365-2982.1998.00098.x
[25]
Bj?rnsson, E.S. and Abrahamsson, H. (1995) Interdigestive Gastroduodenal Manometry in Humans. Indication of Duodenal Phase III as a Retroperistaltic Pump. Acta PhysiologicaScandinavica, 153, 221-230. https://doi.org/10.1111/j.1748-1716.1995.tb09857.x
[26]
White, C.M., Poxon, V. and Alexander-Williams, J. (1981) A Study of Motility of Normal Human Gastroduodenal Region. DigestiveDiseasesandSciences, 26, 609-617. https://doi.org/10.1007/bf01367673
[27]
Jaimes-González, C.V.J., Pereira-Velásquez, M.J., Rodríguez-Fajardo, C.A. and Unigarro-Villota, J.P. (2025) Síndrome de arteria mesentérica superior. Revista ColombianadeCirugía, 40, 155-158. https://doi.org/10.30944/20117582.2558
[28]
Lima, H.S., Maia, A.M. and Castro Neto, A.K.P.D. (2000) Síndrome da artéria mesentérica superior. RevistadoColégioBrasileirodeCirurgi?es, 27, 128-130. https://doi.org/10.1590/s0100-69912000000200012
[29]
Gagner, M. (2015) Safety and Efficacy of a Side-to-Side Duodeno-Ileal Anastomosis for Weight Loss and Type-2 Diabetes: Duodenal Bipartition, a Novel Metabolic Surgery Procedure. AnnalsofSurgicalInnovationandResearch, 9, Article No. 6. https://doi.org/10.1186/s13022-015-0015-0
[30]
Ferrannini, E. and Mingrone, G. (2009) Impact of Different Bariatric Surgical Procedures on Insulin Action and Β-Cell Function in Type 2 Diabetes. Diabetes Care, 32, 514-520. https://doi.org/10.2337/dc08-1762
[31]
Viveiros, O., Rossoni, C., ??ranu, V. and Eiró and Rui Ribeiro, F. (2026) Transit Bipartition: The Shift from Duodenal Exclusion to Preservation. In: Oviedo, R.J., Ed., Metabolicand Bariatric Surgery, Endobariatrics, and AI [Working Title], IntechOpen, 1-20. https://doi.org/10.5772/intechopen.1014991
[32]
Ribeiro, R., Rossoni, C., Rocha, C., Viveiros, O., Taranu, V., Eiró, F., et al. (2026) Post-Bariatric Hypoglycemia: Diagnosis, Mechanisms and Management—A Case Report-Based Review. JournalofClinicalMedicine, 15, Article 3220. https://doi.org/10.3390/jcm15093220
[33]
Carvalho, M.B.D., Jorge, G.M.C.P., Zanardo, L.W., Hamada, L.M., Izabel, L.D.S., Santoro, S., et al. (2024) The Role of FGF19 in Metabolic Regulation: Insights from Preclinical Models to Clinical Trials. AmericanJournalofPhysiology-EndocrinologyandMetabolism, 327, E279-E289. https://doi.org/10.1152/ajpendo.00156.2024
[34]
Noel, P., Madalosso, C.A.S., Reis, P., Ribeiro, R., Layani, L., Jacobs, M., et al. (2026) One Anastomosis Gastric Bypass versus Single Anastomosis Sleeve Jejunal Bypass: Does Duodenal Exclusion Matter? ObesitySurgery, 36, 1922-1931. https://doi.org/10.1007/s11695-026-08553-0
[35]
Santoro, S., Mota, F.C., de Aquino, C.G.G. and de Godoy, E.P. (2025) Common Channel Length and Implications to the Weight Loss. UpdatesinSurgery, 77, 2145-2150. https://doi.org/10.1007/s13304-025-02343-6
[36]
Flynn, C.R., Albaugh, V.L., Cai, S., Cheung-Flynn, J., Williams, P.E., Brucker, R.M., et al. (2015) Bile Diversion to the Distal Small Intestine Has Comparable Metabolic Benefits to Bariatric Surgery. NatureCommunications, 6, Article No. 7715. https://doi.org/10.1038/ncomms8715
[37]
Goncalves, D., Barataud, A., De Vadder, F., Vinera, J., Zitoun, C., Duchampt, A., et al. (2015) Bile Routing Modification Reproduces Key Features of Gastric Bypass in Rat. AnnalsofSurgery, 262, 1006-1015. https://doi.org/10.1097/sla.0000000000001121
[38]
Pierre, J.F., Li, Y., Gomes, C.K., Rao, P., Chang, E.B. and Yin, D.P. (2019) Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR). Obesity, 27, 803-812. https://doi.org/10.1002/oby.22440